NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for November 20111. Global derivatives average daily volume (“ADV”) of 8.3 million contracts in November 2011 increased 0.7% versus the prior year with U.S. equity options increasing 10%. Cash equities ADV in November 2011 were mixed, with European cash trading ADV increasing 8.4% and U.S. cash trading ADV decreasing 9.9% from November 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in November 2011 of 8.3 million contracts increased 0.7% compared to November 2010 and increased 1.4% from October 2011 levels.
• NYSE Euronext European derivatives products ADV in November 2011 of 4.0 million contracts decreased 9.1% compared to November 2010, but increased 16.4% from October 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.3% compared to November 2010 and increased 7.3% from October 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010 levels, but decreased 9.3% from October 2011. NYSE Euronext’s U.S. options exchanges accounted for a record 28.1% of total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% recorded in October 2011.
• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011.
• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% from October 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.1 billion shares in November 2011 decreased 9.9% compared to November 2010 and decreased 15.5% compared to October 2011. NYSE Euronext’s Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.
• There were a total of 22 trading days in Europe and 21 trading days in the U.S. in November 2011 compared to 22 trading days in Europe and 21 trading days in the U.S. in November 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in November 2011 was 4.0 million futures and options contracts, a decrease of 9.1% from November 2010, but an increase of 16.4% from October 2011.
• The 4.0 million in European derivatives futures and options contracts ADV in November 2011 consisted of 3.1 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 21.5%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 2.3% compared to November 2010, but increased 7.3% from October 2011.
• Year-to-date, European derivatives products ADV of 4.6 million contracts was 6.5% below prior year levels. The 4.6 million in futures and options contracts ADV year-to-date consisted of 3.4 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 24.8%, executed through Bclear.
• Total fixed income products ADV of 2.1 million contracts in November 2011 increased 6.5% from November 2010 and increased 12.4% from October 2011. Year-to-date, total fixed income products ADV of 2.3 million contracts was 1.1% below prior year levels.
• Total equity products (including Bclear) ADV of 1.8 million contracts in November 2011 decreased 23.0% compared to November 2010, but increased 23.4% from October 2011. The 1.8 million contracts in equity products ADV consisted of 1.2 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.2 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 30.4% decrease compared to November 2010 and 0.5 million in options contracts, which represented a 27.1% decrease compared to November 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.1 million contracts were 12.6% below prior year levels.
• Total commodities products ADV of 68,000 contracts in November 2011 increased 1.3% compared to November 2010, but decreased 14.1% compared to October 2011. Year-to-date, total commodities product ADV of 82,000 contracts was 26.4% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010, but decreased 9.3% compared to October 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 20.2% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 3.4% to 15.1 million contracts in November 2011 compared to November 2010 and decreased 9.3% compared to October 2011. Year-to-date, U.S. consolidated equity options ADV of 17.0 million contracts was 18.8% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for a record 28.1% of the total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% in October 2011.
• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011. Year-to-date, U.S. futures and futures options ADV of 80,400 contracts was 387.5% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% compared to October 2011.
• Year-to-date, European cash products ADV of 1.7 million transactions was 17.5% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in November 2011 decreased 9.9% to 2.1 billion shares compared to November 2010 and decreased 15.5% from October 2011.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 12.3% from prior year levels.
• NYSE Euronext’s Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 320 million shares in November 2011 increased 1.6% compared to November 2010, but decreased 20.1% compared to October 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 331 million shares was 3.8% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary

                                                            Average Daily Volume Total Volume Average Daily Volume Total Volume % Chg vs. % Chg vs. (Unaudited; contracts in thousands) Nov-11 Nov-10 % Chg Nov-11 Nov-10 % Chg YTD 2011 YTD 2010 YTD 2011 YTD 2010   Number of Trading Days - European Markets 22 22 22 22 236 236 Number of Trading Days - U.S. Markets 21 21 21 21 231 231   European Derivatives Products 3,974 4,373 -9.1% 87,432 96,199 -9.1% 4,560 -6.5% 1,076,252 -6.1% of which Bclear 855 1,180 -27.5% 18,811 25,956 -27.5% 1,132 -16.9% 267,197 -16.5%   Total Fixed Income Products 2,136 2,006 6.5% 46,998 44,137 6.5% 2,330 -1.1% 549,865 -0.7%   Short Term Interest Rate Products 1,963 1,834 7.0% 43,195 40,355 7.0% 2,186 -2.2% 515,916 -1.8% Medium and Long Term Interest Rate Products 1 173 172 0.6% 3,803 3,781 0.6% 144 18.4% 33,948 18.9%   Total Equity Products 2 1,770 2,299 -23.0% 38,930 50,578 -23.0% 2,149 -12.6% 507,081 -12.2%   Individual Equity Products 1,240 1,747 -29.0% 27,275 38,437 -29.0% 1,563 -15.5% 368,895 -15.2% Futures 706 1,015 -30.4% 15,539 22,338 -30.4% 967 -16.6% 228,274 -16.2% Options 533 732 -27.1% 11,737 16,099 -27.1% 596 -13.8% 140,621 -13.4% Equity Index Products 530 552 -4.0% 11,654 12,140 -4.0% 586 -3.6% 138,186 -3.2%   of which Bclear 855 1,180 -27.5% 18,811 25,956 -27.5% 1,132 -16.9% 267,197 -16.5% Individual Equity Products 787 1,100 -28.4% 17,320 24,199 -28.4% 1,053 -17.0% 248,399 -16.6% Futures 681 1,008 -32.4% 14,987 22,173 -32.4% 950 -17.7% 224,259 -17.4% Options 106 92 15.2% 2,333 2,025 15.2% 102 -9.6% 24,139 -9.2% Equity Index Products 68 80 -15.2% 1,490 1,757 -15.2% 80 -15.5% 18,799 -15.2%   Commodity Products 68 67 1.3% 1,504 1,484 1.3% 82 26.4% 19,307 26.9%   U.S. Derivatives Products   Equity Options 3   NYSE Euronext Options Contracts 4,244 3,860 10.0% 89,127 81,057 10.0% 4,448 20.2% 1,027,537 20.7% Total Consolidated Options Contracts 15,119 15,657 -3.4% 317,497 328,798 -3.4% 16,995 18.8% 3,925,903 19.3%   NYSE Group Share of Total 28.1% 24.7% 28.1% 24.7% 26.2% 0.3% 26.2% 0.3%   NYSE Liffe U.S.  

Futures and Futures Options Volume*

88.5 19.0 366.3% 1,947 399 388.5% 80.4 387.5% 19,055.2 402.4%   European Cash Products (trades in thousands) 1,671 1,541 8.4% 36,756 33,903 8.4% 1,744 17.5% 411,623 18.0%   Equities 1,602 1,473 8.7% 35,243 32,416 8.7% 1,676 17.6% 395,494 18.1% Exchange-Traded Funds 22 19 14.3% 483 423 14.3% 21 17.0% 4,944 17.5% Structured Products 42 42 -1.3% 922 934 -1.3% 42 16.7% 10,007 17.2% Bonds 5 6 -16.7% 108 129 -16.7% 5 -13.2% 1,177 -12.8%   U.S. Cash Products (shares in millions) 5 2,108 2,339 -9.9% 44,272 49,129 -9.9% 2,327 -12.3% 537,541 -11.9%   NYSE Listed (Tape A) Issues 4   Handled Volume 5 1,466 1,671 -12.3% 30,790 35,101 -12.3% 1,637 -14.8% 378,088 -14.4% Matched Volume 6 1,391 1,583 -12.1% 29,219 33,244 -12.1% 1,552 -13.9% 358,418 -13.5% Total NYSE Listed Consolidated Volume 4,083 4,391 -7.0% 85,749 92,209 -7.0% 4,438 -10.3% 1,025,181 -9.9%   Share of Total Consolidated Volume Handled Volume 5 35.9% 38.1% -2.2% 35.9% 38.1% -2.2% 36.9% -1.9% 36.9% -1.9% Matched Volume 6 34.1% 36.1% -2.0% 34.1% 36.1% -2.0% 35.0% -1.5% 35.0% -1.5%   NYSE Arca & Amex (Tape B) Listed Issues   Handled Volume 5 368 366 0.6% 7,738 7,694 0.6% 389 -1.9% 89,848 -1.5% Matched Volume 6 333 332 0.4% 6,988 6,963 0.4% 350 -1.7% 80,943 -1.3% Total NYSE Arca & Amex Listed Consolidated Volume 1,422 1,357 4.8% 29,868 28,496 4.8% 1,501 0.5% 346,829 1.0%   Share of Total Consolidated Volume Handled Volume 5 25.9% 27.0% -1.1% 25.9% 27.0% -1.1% 25.9% -0.7% 25.9% -0.7% Matched Volume 6 23.4% 24.4% -1.0% 23.4% 24.4% -1.0% 23.3% -0.5% 23.3% -0.5%   Nasdaq Listed (Tape C) Issues   Handled Volume 5 274 302 -9.3% 5,744 6,334 -9.3% 301 -10.2% 69,605 -9.8% Matched Volume 6 236 257 -8.0% 4,963 5,394 -8.0% 260 -8.3% 59,963 -7.9% Total Nasdaq Listed Consolidated Volume 1,857 1,984 -6.4% 38,997 41,665 -6.4% 2,058 -8.1% 475,511 -7.7%   Share of Total Consolidated Volume Handled Volume 5 14.7% 15.2% -0.5% 14.7% 15.2% -0.5% 14.6% -0.3% 14.6% -0.3% Matched Volume 6 12.7% 12.9% -0.2% 12.7% 12.9% -0.2% 12.6% 0.0% 12.6% 0.0%   Exchange-Traded Funds 5,7   Handled Volume 5 355 348 1.9% 7,453 7,312 1.9% 367 -3.8% 84,887 -3.4% Matched Volume 6 320 315 1.6% 6,728 6,624 1.6% 331 -3.8% 76,430 -3.4% Total ETF Consolidated Volume 1,400 1,303 7.5% 29,409 27,361 7.5% 1,446 -1.8% 333,924 -1.4%   Share of Total Consolidated Volume Handled Volume 5 25.3% 26.7% -1.4% 25.3% 26.7% -1.4% 25.4% -0.5% 25.4% -0.5% Matched Volume 6 22.9% 24.2% -1.3% 22.9% 24.2% -1.3% 22.9% -0.5% 22.9% -0.5%   1     Data includes currency products.

2

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 3 Includes trading in U.S. equity options contracts, not equity-index options. 4 Includes all volume executed in NYSE Group crossing sessions. 5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 7 Data included in previously identified categories. * ADVs calculated with the appropriate number of NYSE Liffe U.S. trading. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.